Xylem Inc. — Form 8-K
Filed July 28, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 52/100
What the filing says
Xylem reported Q2 2026 orders of $3.1B (up 42% reported, 41% organic) and revenue of $2.3B (up 2% reported, 1% organic). Diluted EPS was $1.11 (up 19%); adjusted EPS $1.46 (up 16%). The company raised full-year 2026 guidance to $9.2B revenue (2% growth vs. prior 2–3%) and adjusted EPS $5.55–$5.70 (up from $5.35–$5.60), citing strong order momentum, margin expansion to 23.1–23.5% adjusted EBITDA, and broadening demand from AI infrastructure and industrial sectors. Long-term debt increased $987M to $2.9B combined short/long-term; share repurchases totaled $1.24B year-to-date.
Why this rating
Orders surge and raised full-year EPS guidance are material near-term positives. However, revenue growth remains modest (1–2% organic), margin expansion is modest (90–130 bps), and EPS raise is modest (~2.8% midpoint). At $31B market cap, a $3.1B quarterly order base and modest organic revenue growth represent solid but not transformational momentum. Debt increased materially but remains manageable. A meaningful positive signal, but execution and sustaining growth remain key.
See more from July 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.